Category
Ruxolitinib
CAS Number
2950130-23-9
Molecular Formula
C₁₈H₂₁N₅O₂
Molecular Weight
339.4 g/mol
Synonym

methyl (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanoate

Keywords
Impurities
Impurities manufacturer and Suppliers in Hyderabad india
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Manasa Life Sciences in Hyderabad, India, provides the high-quality Ruxolitinib methyl ester impurity (CAS: 2950130-23-9; Formula: C₁₈H₂₁N₅O₂; MW: 339.4 g/mol and chemical name methyl (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanoate) for reliable analytical validation and quality control. Our synthesis and analytical R&D teams utilize cutting-edge HPLC, LCMS, NMR, and IR analytical technologies to maintain the highest purity standards under GMP and GDP protocols. We strictly follow EP, USP, USFDA, EMA, and ICH regulatory guidelines, ensuring every product is backed by a rigorous COA and MSDS. This documentation ensures you receive accurate chemical identification, molecular formula, and weight data essential for your stability studies and regulatory reporting. By choosing Manasa Life Sciences, you gain a partner dedicated to transparency, technical excellence, and scientific rigor. We support your goal of producing safe and effective medications by delivering the high-precision reference materials you need to remain compliant and ahead of the curve in pharmaceutical analysis.